Enter your login e-mail to the account
Search
- Hereditary breast ovarian cancer: molecular-genetic analysis of BRCA genes
doc. MUDr. Juraj Kaušitz, CSc., RNDr. Zdena Bartošová, CSc., RNDr. Miriam Milly, PhD., RNDr. Michal Konečný, PhD., RNDr. Katarína Závodná, PhD., RNDr. Eva Weismanová, PhD.
(2/2010, Review articles ) - Prophylactic procedures in women with gene mutations BRCA1 and BRCA2
doc. MUDr. Vladimír Bella, PhD.
(2/2012, Main topic ) - Molecular-genetic analysis of hereditary breast/ovarian cancer: Results of mutation testing of BRCA1 and BRCA2 genes
doc. MUDr. Juraj Kaušitz, CSc., RNDr. Miriam Milly, PhD., RNDr. Katarína Závodná, PhD., doc. MUDr. Denisa Ilenčíková, PhD., RNDr. Michal Konečný, Ing. Ľudmila Vavrová, PhD., MUDr. Iveta Mlkvá
(2/2012, Main topic ) - Poly (ADP-ribose) polymerase inhibitors in the treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(5/2017, Review articles ) - Rare ovarian tumors
MUDr. Róbert Biel
(4/2019, Main topic ) - Comprehensive treatment of epithelial ovarian cancer
MUDr. Tibor Packaň, PhD.
(5/2011, Review articles ) - Zriedkavý nádor hrudníka: malígny pleurálny mezotelióm
MUDr. Lucia Denková, MUDr. František Sándor, PhD., FCCP
(3/2018, Main topic ) - The role of PARP inhibitors in the treatment of breast cancer
MUDr. Eliška Volochová, MUDr. Marián Streško, PhD.
(2/2022, Main topic ) - Optimal management of patients with breast cancer after progression on CDK4/6 inhibitors.
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(2/2022, Main topic ) - Gravidita po onkologickej liečbe
MUDr. Katarína Rejleková, PhD.
(3/2018, Review articles ) - Advances in the treatment of triple- negative breast cancer
MUDr. Lea Balážová, doc. MUDr. Igor Andrašina, CSc.
(5/2022, Review articles ) - Molecular pathology of selected types of ovarian cancer
doc. MUDr. Karol Kajo, PhD.
(5/2014, Main topic ) - Genetic counseling as part of genetic analysis
RNDr. Zdena Bartošová, CSc., RNDr. Michal Konečný, PhD., doc. MUDr. Denisa Ilenčíková, PhD., MUDr. Olívia Hamidová
(2/2015, Main topic ) - Molecular cythogenetic in the familial cancers
Ing. Martin Čermák
(2/2015, Main topic ) - Hereditary cancer syndromes
RNDr. Miriam Milly, PhD., RNDr. Michal Konečný, PhD., Ing. Ľudmila Vavrová, PhD., MUDr. Olívia Hamidová, RNDr. Katarína Závodná, PhD.1, Mgr. Lenka Dolešová
(2/2015, Main topic ) - The role of PARP inhibitors in the treatment of ovarian cancer
doc. MUDr. Lýdia Heľpianska, CSc.
(4/2021, Main topic ) - News in systemic treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(6/2018, Review articles )